IGFBP7 and acute kidney injury: [TIMP-2] × [IGFBP7] showed a fair predictive ability for AKI development (AUC 0.75, Sens 83%, Spec 59%), as well as PCT (AUC 0.79, Sens 79%, Spec 67%).